ArticleThe New England journal of medicine2016
Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance.
Abstract readHistorical Article
In one paragraph
Article in The New England journal of medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
56 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.American journal of respiratory and critical care medicine · 2019Guideline
- First-Time-in-Human Study and Prediction of Early Bactericidal Activity for GSK3036656, a Potent Leucyl-tRNA Synthetase Inhibitor for Tuberculosis Treatment.Antimicrobial agents and chemotherapy · 2019Trial
- Trial
- Rates and risk factors of monoresistance against isoniazid and multidrug-resistant tuberculosis in Almaty, Kazakhstan.BMC infectious diseases · 2026Article
- Machine learning-based analysis of drug resistance mutations in Mycobacterium tuberculosis.PloS one · 2026Article
- Whole-genome sequencing reveals lineage-associated drug resistance and enables machine learning-based prediction inFrontiers in microbiology · 2026Article
- Tuberculous/BCG-Related Chronic Orchiepididymitis With Fistulization: Expanded Case Report and Literature Review.Case reports in urology · 2026Article
- Article
- Guidance for infectious disease care in the face of human conflict: a case-based narrative review.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025Review
- Tuberculosis laboratory capacity building in the WHO African Region: The past, the present and the future: A Viewpoint.PLOS global public health · 2025Review
- Association of bacteriomes with drug susceptibility in lesions of pulmonary tuberculosis patients.Heliyon · 2024Article
- New option: targeting RNase J and RNase HI in the fight against multi-drug-resistant tuberculosis.Annals of medicine and surgery (2012) · 2024Article
- NMI-SOPharmaceuticals (Basel, Switzerland) · 2024Article
- Evaluation of Anti-Inflammatory and Anti-Tubercular Activity of 4-Methyl-7-Substituted Coumarin Hybrids and Their Structure Activity Relationships.Pharmaceuticals (Basel, Switzerland) · 2023Article
- Burden of Pulmonary Rifampicin-Resistant Tuberculosis in Kajiado, Kenya: An Observational Study.Microorganisms · 2023Article
- Mechanisms of aPharmaceutics · 2023Article
- 25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward.The Lancet. Infectious diseases · 2022Review
- Multidrug-resistant tuberculosis in Sierra Leone.The Lancet. Global health · 2022Article
- Application of Amplicon-Based Targeted NGS Technology for Diagnosis of Drug-Resistant Tuberculosis Using FFPE Specimens.Microbiology spectrum · 2022Article
- Machine Learning Models forMolecular pharmaceutics · 2022Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
17 authors.
Matteo ZignolFrom the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).
Anna S DeanFrom the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).
Dennis FalzonFrom the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).
Wayne van GemertFrom the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).
Abigail WrightFrom the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).
Armand van DeunFrom the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).
Françoise PortaelsFrom the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).
Adalbert LaszloFrom the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).
Marcos A EspinalFrom the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).
Ariel Pablos-MéndezFrom the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).
Amy BloomFrom the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).
Mohamed A AzizFrom the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).
Karin WeyerFrom the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).
Ernesto JaramilloFrom the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).
Paul NunnFrom the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).
Katherine FloydFrom the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).
Mario C RaviglioneFrom the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).
Funding
World Health Organization 001
Abstract
PubMed holds no abstract for this paper.
Indexed as
Drug Resistance, BacterialAntitubercular AgentsGlobal HealthHistory, 20th CenturyHistory, 21st CenturyHumansMycobacterium tuberculosisPopulation SurveillanceTuberculosis, Multidrug-ResistantAntitubercular Agents
Identifiers
PMID
27626523What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.